Immediate Impact

4 by Nobel laureates 6 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

Mechanisms of long COVID and the path toward therapeutics
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
3 intermediate papers

Works of Candido E. Rivera being referenced

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib
2015
The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cellsin vitro, as a single agent and in combination with other drugs
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Candido E. Rivera 811 840 386 542 49 1.7k
H. L. Haak 525 1097 285 315 41 1.8k
P. W. Wijermans 298 779 325 314 49 1.5k
Herman Nilsson‐Ehle 581 550 793 250 58 2.0k
Federico Campigotto 363 630 138 826 40 1.9k
Brady L. Stein 1213 965 140 796 105 2.0k
Christine Devalck 832 739 358 314 71 1.9k
Rajko Kušec 859 996 326 960 97 2.0k
Johan Lanng Nielsen 409 1237 138 607 63 1.9k
Jeffrey S. Wasser 202 892 245 238 48 2.0k
W. Paul Bowman 324 908 285 344 50 2.1k

All Works

Loading papers...

Rankless by CCL
2026